Skip to main content
. Author manuscript; available in PMC: 2023 Mar 14.
Published in final edited form as: Cancer Cell. 2022 Feb 10;40(3):255–276. doi: 10.1016/j.ccell.2022.01.006

Figure 2. Overview of nanobiomaterial applications for targeted cancer immunotherapy.

Figure 2.

Major applications for targeted nanobiomaterials include anti-cancer vaccines, immune checkpoint inhibition (ICI), immunogenic cell death (ICD), and chemotherapy. Abbreviations: tumor-associated macrophages (TAMs); dendritic cells (DCs); antigen (Ag).